Skip Navigation

Advertise|Press|Contact|FAQ|About Us


Home » Clinical Trials » Diabetic Retinopathy

Clinical Trial Details


Research Study Summary

A clinical trial seeking patients for a research study for the treatment of Diabetic Retinopathy

Research Study Title

A Phase 3 Safety and Efficacy Study of Vitreosolve® for Four Ophthalmic Intravitreal Injections For Inducing Posterior Vitreous Detachment in Retinopathy Patients.


The purpose of this study is to determine the safety and efficacy of Vitreosolve® in diabetic retinopathy patients.

To Learn more



Both Male and Female


50 and up

Overall Status


Lead Sponsor

Vitreoretinal Technologies, Inc.


21 Months

Facility Type



Both Male and Female ages 50 Years and up

Inclusion Criteria:

  • Subjects with a history of systemic diabetes(type I,or II)

  • Subject with a documented history of Non- proliferative Diabetic Retinopathy(NPDR)

  • Subjects with no or partial PVD at baseline exam in study eye.

Exclusion Criteria:

  • Subjects with retinal pathology in the study eye other then (NPDR)

  • Subjects with high myopia in the study eye

  • Subjects who have monocular vision or central lateral vision of 20/200 or worse BCVA in the non-study eye.

  • Subjects with an aphakic study eye or if pseudophakic, cataract extraction surgery less then 6 months prior to study enrollment.

  • Subjects that have either vitrectomy surgery, intavitreal injections, or laser treatments in the study eye.

Site Locations (5)

Country State City Zip Facility and Contact
India AP Vizag LVPEI
India Kochi Amrita
Mexico Coyoacan San Lucas La Ceguera
Mexico DF Mexico City Conde De Valenciana
Mexico Neuvo Leon Monterrey Hidalgo


Philip N Calvillo
949-753-1008 ext. 120

NCT ID: NCT00908778

Date Last Changed: October 19, 2009

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials. Some study summaries have been edited for clarity purposes to make them easier to understand. View more study details here.